Prosle

Prosle 5mg Tablets

Solifenacin

Horizon Pharmaceuticals (Pvt) Limited

Drug Identity

Active Ingredient
Solifenacin
Drug Class
Drugs For Urinary Frequency And Incontinence
0

How to Take It

Dosage information not available for this product.

Safety Alerts

Urinary retention, severe GI conditions, toxic megacolon, myasthenia gravis, narrow-angle glaucoma, haemodialysis, severe hepatic impairment

Important Warnings

Bladder outflow obstruction at risk of urinary retention, GI obstruction, risk of oesophagitis, reduced GI motility, severe renal or moderate hepatic impairment, autonomic neuropathy, hiatus hernia, oesophageal reflux, neurogenic bladder disorder, susceptibility to QT-interval prolongation

Side Effects

Gastro-oesophageal refluxoedemadysphoniahepatic impairmenthyperkalaemiamuscle weaknessreduced appetitetorsade de pointesdry mouthGI upsetblurred vision.

Drug Interactions

Inhibitors
inducers or substrates of CYP3A4
cholinergic agonists
anticholinergics
GI motility stimulants.

Pregnancy & Lactation

Pregnancy
Avoid, use only when potential benefit outweighs risk.
Lactation
Caution advised, avoid

Price Intelligence

Rs 2,232.72
DRAP approved maximum price · per unit · approved 27 Jul, 2026
No retail price observed for this pack. Retailers may not exceed the approved maximum.
Prices across sources
No retail prices recorded

Should you consider an alternative?

Other options containing Solifenacin, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.